Most Medicaid Programs, U.S. Insurers Will Cover Fuzeon Costs
At $19,900 for a year's supply, the HIV drug Fuzeon (T-20) costs more
than twice as much as any other HIV treatment. But 94 percent of the
U.S.'s 142 largest insurers have agreed to cover this drug, as have
Medicaid programs in 48 states.
HIV Treatment: What It's All About
Starting treatment? Read this guide to the nuts and bolts of HIV treatment, from Positively Aware.
Also check out The Body's collection of articles on starting treatment. It includes information on when to start, advice on what to keep in mind when you begin HAART, and personal essays
from people who've been there before.
Have a question about when to start HIV treatment or what to start
with? Ask The Body's online experts Dr. Ben Young and Dr. David Wohl!
HIV Vaccine Day Passes as Skepticism Grows
May 18 was International HIV Vaccine Awareness Day. It's a day to
thank the thousands of people working on an HIV vaccine. To show
support for them, many people wore an AIDS ribbon upside-down to
form a "V" for "vaccines," a vision of a world without AIDS, and a
symbol of the urgent need to stop the spread of HIV/AIDS. Click here to read the U.S. National Institutes of Health's press release.
Nearly half of African Americans surveyed (48 percent) and more
than a quarter of Hispanics (28 percent) believe that an HIV
vaccine already exists and is being kept a secret. Twenty percent
of adults in the general population share that belief. To help
reduce these numbers, the U.S. National Institute of Allergy and
Infectious Diseases is trying to educate the general public about
How HIV Works: An Easy-to-Understand Guide
Don't you wish you could get a solid, down-to-earth, understandable
explanation of how HIV works without having to learn a thousand new
medical terms in the process? This brief, illustrated overview from
Glaxo will take you through the basics.
The Key to Adherence: Empowering Patients
An international group of HIV specialists met recently to talk
about how difficult it is for some people with HIV to adhere to
their HAART regimens. Patients, they agreed, should be informed
from the beginning about the risks, uncertainties, side effects
and pill burdens involved when taking different regimens. Armed
with this knowledge, those patients should take part in the final
decision about what type of treatment is most appropriate.
HIV Spread Going From Bad to Worse in Russia
If HIV continues to spread at its current rate, 10 million to 12
million Russians may become infected by 2010, a Russian official
said at a recent press conference. Russia officially has about
200,000 people living with HIV, though some estimates put the actual number of infected at up to 1.5 million.
HIVers and the Americans With Disabilities Act
What exactly is the Americans With Disabilities Act (ADA), and what
does it do for people with HIV? This collection of questions and answers about the ADA will fill you in.
Metabolic Problems: Treatment Guidelines
Many different types of health problems -- lipodystrophy, diabetes,
high cholesterol and bone disease, to name a few -- are part of a
group of problems called "metabolic complications." HIVers tend to
be at higher risk for these complications, but there's a new set of
international guidelines created to help HIV doctors manage them.
Adherence Solutions for Homeless HIVers
Forty homeless men with HIV were recruited in Edmonton, Canada to
see if once they were moved off the streets to stable housing --
not shelters -- they would be able to steadily take their HIV
medications. For the results, click here.
New Protease Inhibitor Nears U.S. Approval
Within the next month, we're likely to see the approval of the
first once-a-day protease inhibitor. Known as atazanavir or by
its commercial name, Reyataz, it'll be used in combination with
other drugs mostly as a first-line HIV treatment -- and may not be
as bad for HIVers' cholesterol levels as other protease inhibitors.
Want to learn more about it? The Body has a large collection of
articles covering everything from the basics on atazanavir to the
Dead Monkeys and War: How an HIV-2 Epidemic Was Born
An international group of researchers think they've figured out how
and when HIV-2, the strain of HIV now decimating sub-Saharan Africa,
began to spread to humans. Their theory: Humans first got it when
slaughtering monkeys in the 1940s, then passed it to others during
the African wars of independence in the 1960s and 1970s.
What Happens When Smallpox Vaccines and HIV Mix?
What are the risks of smallpox vaccination for people with HIV? Will
the smallpox vaccine cause HIV to progress? How much does CD4 count
matter? This article has the answers.
U.S. Global AIDS Bill Nears Final Approval
By a voice vote, the U.S. Senate agreed to give President Bush the
$15 billion he sought to fight global AIDS and to prod the rest of
the world's wealthy nations to follow America's lead. The Senate's
version of the bill (which includes some debt relief for poor
countries) must now be approved by the House of Representatives
before the President can sign it.
Even after the U.S.'s massive $15 billion global is signed by the
President, government officials will still need to argue over how
much of that money they'll actually put into next year's budget.
Through the entire process, The Body's collection of news and
analysis articles will keep you updated and informed!
Could HAART Cause Muscle Damage?
Researchers in Italy were surprised to find that a
higher-than-expected number of people who take HAART might be
at risk for muscle damage. Males and anyone taking Zerit (d4T,
stavudine) seemed to be at higher risk than others.
Women: Get Yourself the Sex You Want!
Few women are lucky enough to reach adulthood with a full
understanding of their bodies, and particularly of their
sexuality. Laura Jones of Positively Aware provides some helpful
advice and resources.
Mexican Bishops Equate Condom Advocacy With "Depravity"
Leading Mexican clergy have attacked the country's first lady, Marta Sahagun, for advocating the use of condoms as protection against AIDS.
Keeping Thrush at Bay
The best way for someone with HIV to avoid candidiasis, a fungal
infection known as thrush when it occurs in the mouth, is to keep
his or her CD4 count from dropping below 200. STEP Ezine provides
more information in this brief overview.
Psychiatric Problems in HIVers
Some people with HIV also suffer from mental health problems -- but
how, and why? Understanding the answers to these questions can be
extremely important in helping doctors determine the best treatment.
This slide presentation from Ewald Horwath, M.D., provides an
overview of these issues.
HIV Treatment Newsletter for Limited-Resource Areas
"HIV & AIDS Treatment in Practice" is a new e-mail
newsletter available for healthcare providers working in
limited-resource settings throughout the world. Click here to
read more about the newsletter, which will publish twice a month.
A Selection of the Top HIV/AIDS Stories From Across the Internet:
HIV's History Traced: U.S. Virus Arrived Early and Spread Fast
New evidence suggests HIV arrived in the U.S. around 1968 and immediately spread "like wildfire"
From Nature Magazine (May 20, 2003)
Kaiser Family Foundation, NCPTP Studies "Paint Portrait" of Youth Sexual Activity, Attitudes
Among their findings: About 10 percent of respondents think it's "not a big deal" to occasionally have sex without a condom
From Kaiser Daily HIV/AIDS Report (May 20, 2003)
Global Health Experts Concerned Countries Not Prepared to Handle Influx of Funds to Treat HIV-Positive Individuals
Many developing nations might not have the tools or knowledge they need to scale up their treatment programs, advocates say
From Kaiser Daily HIV/AIDS Report (May 19, 2003)
Metabolic Complications of HIV Therapy
A highly thorough overview of lipodystophy, insulin resistance, bone disease and other HIV/HAART-related metabolic problems
From HIV InSite (May 2003)
Introduction: Integrating Nutrition Therapy Into Medical Management of Human Immunodeficiency Virus
A comprehensive look at general nutritional management, evaluation
and intervention for wasting, insulin resistance, fat redistribution,
dyslipidemia, lactic acidosis, food safety and bone abnormalities for
people living with HIV
From Clinical Infectious Diseases (April 1, 2003)
AIDS Has a Woman's Face: Gender and Power: New Strategies for HIV Prevention
Audio and slide presentations from a University of California-San
From HIV InSite (March 7, 2003)